The 15-month Phase 1 study will begin on September 1, 2010. The first three months will be used to assemble the expert committee that will be responsible for carrying out the Phase 1 study. The committee will be comprised of 20 members, including up to 2 experts from outside of the United States, with the following collective expertise:

• Demography/spatial analysis
• Dosimetry
• Epidemiology (radiation and general)
• Health physics
• Industrial toxicology
• Medicine/oncology
• Nuclear engineering (familiarity with nuclear plant operations)
• Public health
• Radiobiology
• Radionuclide fate and transport and modeling (air and water)
• Risk communication/public communication
• Social science (environmental justice)
• Statistics/Biostatistics

The committee will hold 5 meetings to gather information and develop a consensus report with findings and recommendations. This report will be released to the study sponsor and to the public at the conclusion of the Phase 1 study.